SlideShare a Scribd company logo
1 of 10
Kacy Juneau
Ian Wall
Sade Adelakun
Janelle Harrison
Report 5
1. Summary of Last Year’s Performance:
For period seven we had an increase in all of our fields. Our net income is in a
growth stage at 26.2 and our revenue is in a growth state at 6.1%. The gross margin is
in a growth stage at 13.5%, and finally our stock price increased again from $81.60 to
$96.69. Our social media is still generating good comments and feedback from both of
our medications. We listened to our Allround customers and gave them coupons this
period. Allstar’s consumer satisfaction for period seven increased some what for
Allround+ at 48.5% and Allround decreased slightly at 63.5%. We increased the price
for both Allround and Allround+ in period seven. Allround was sold at a manufacturing
price of $7.04 and sold 111,800,000 units, which is down from last period. Allround+
was sold at a $6.79 manufacturing price with 28,400,000 units sold, which is a growth
from last period. Our brand awareness for Allround is 84% and Allround+ is 58.2%.
2. Sales Force Allocation:
Sales Force
Allround P7 P8 Change Sales Increase/ Decrease Expected
Direct:
Ind. Drug 13 13 0 3,600,000/13=276,923.1 x0= 0
Chain Drug 35 35 0 23,500,000/35=671,428.57 x0 =0
Grocery Stores 56 55 -1 29,000,000/56=517,857.14 x(-1) = -517,857.14 loss
Conv. Stores 5 5 0 900,000/5=180,000 x0= 0
Mass Merch. 16 16 0 12,400,000/16=775,000 x 0= 0
Total Direct: 125 124 -1 =517,857.14 loss
Indirect/Wholesalers:
Wholesaler Support: 19 18 -1 Data not given
Merchandisers 13 14 +1 Data not given
Detailers 17 17 0 Data not given
Total
Indirect/Wholesalers: 49 49 0 42,500,000/49=867,346.94x0= 0
Total Overall: 174 173 -1 0-517,857.14= 517,857.14 units lost
Kacy Juneau
Ian Wall
Sade Adelakun
Janelle Harrison
SalesForce
Allround+ P7 P8 Change Sales Increase/ Decrease Expected
Direct:
Ind. Drug 13 13 0 1,900,000/13=146,153.85x 0= 0
Chain Drug 35 35 0 6,200,000/35=177,142.86x 0=0
Grocery Stores 56 55 -1 6,000,000/56=107,142.86 x(-1)=107,142.86 loss
Conv. Stores 5 5 0 100,000/5=20,000 x 0= 0
Mass Merch. 16 16 0 2,300,000/16=143,750x 0= 0
Total Direct: 125 124 -1 107,142.86 loss
Indirect/Wholesalers:
Wholesaler Support: 19 18 -1 Data not given
Merchandisers 13 14 +1 Data not given
Detailers 17 17 0 Data not given
Total
Indirect/Wholesalers: 49 49 0 11,800,000/49=240,816.33 x0= 0
Total Overall: 174 173 -1 0- 107,142.86= 107,142.86 units lost
For the last few periods we have taken the industry averages for direct and
indirect sales force and used those calculations to determine what numbers we should
use for our company Allstar. From the math calculations below you can see how we
found the industry averages for period seven. I decided to round up all the averages
that were .2 or higher up. From doing it this way our numbers barely change from the
previous period and we still reach our goal of being in the average for indirect and direct
sales force. Also being in the average helps us to not push more than needed in the
market. This strategy will help us compete with our competitors and not spend more
than needed on sales force.
Period 7 ALLSTAR B&B CURALL DRISCOL ETHIK AVERAGE:
DIRECT
INDEP
DRUGSTORES
13 14 19 5 10 61/5=12.2
CHAIN
DRUGSTORES
35 45 41 18 32 171/5=34.2
Kacy Juneau
Ian Wall
Sade Adelakun
Janelle Harrison
GROCERY
STORES
56 80 57 29 50 272/5=54.4
CONV. STORES 5 9 3 1 4 22/5=4.4
MASSMERCH 16 28 12 8 12 76/5=15.2
INDIRECT
WHOLESALER
SUPP
19 25 22 11 13 90/5=18
MERCHANDISE
RS
13 18 18 7 12 68/5=13.6
DETAILERS 17 30 14 5 17 83/5=16.6
3. Consumer & Trade Promotions:
Promotions
Allround P7 P8 Change
Sales Increase/Decrease
Expected
Promotion
Allowance
Independent
Drugstores 15.74% 15.74% 0%
Chain
Drugstores 15.74% 15.74% 0%
Grocery Stores 15.74% 15.74% 0%
Convenience
Stores 15.74% 15.74% 0%
Mass
Merchandisers 15.74% 15.74% 0%
Wholesalers 15.74 15.74% 0%
Co-op
Advertising $800,000 $800,000 $0.00
Point of
Purchase $893,000 $893,000 $0.00
Trial Size $0.00 $0.00 $0.00
Coupon Budget $4,000,000 $0.00 -$4,000,000
Total: $5,693,000 $1,693,000 -4,000,000 111,800,000/5,693,000=19.64X -
Kacy Juneau
Ian Wall
Sade Adelakun
Janelle Harrison
4,000,000= -78,560,000 decrease
Allround+ P7 P8 Change
Sales Increase/Decrease
Expected
Promotion
Allowance
Independent
Drugstores 18% 18% 0%
Chain
Drugstores 18% 18% 0%
Grocery Stores 11.7% 11.7% 0%
Convenience
Stores 11.7% 11.7% 0%
Mass
Merchandisers 11.7 11.7% 0%
Wholesalers 18% 18% 0%
Co-op
Advertising $2,500,000 $607,143 -$1,892,857
Point of
Purchase $1,500,000 $1,097,714 -$402,286
Trial Size $1,000,000 $0.00 -$1,000,000
Coupon Budget $4,000,000 $4,000,000 $0.00
Total: $9,000,000 $5,705,428 -$3,294,572
28,400,000/9,000,000=3.156 X -
$3,294,572= -10,397,669 decrease
Allround remains the leading product in the industry with the highest brand
awareness, purchase intentions, and shelf space. However, each of these values have
dropped slightly. Currently, brand awareness is 84%, which is .05% less than last
period. Purchase intentions are now 19.2%, which is 2% less than last period. Finally,
the overall shelf space across all channels is now 1.6, which is .01 less than last period.
These values have likely dropped due to a reduction in the promotional allowance for all
channels, but we still provide a higher allowance than ten out of twelve of the competing
brands including our closest competitor, Besthelp. With that in mind, we will keep
Kacy Juneau
Ian Wall
Sade Adelakun
Janelle Harrison
promotional allowance at 15.7% in all channels, but if brand awareness, purchase
intentions, and shelf space continue to decline then we will increase the allowance for
all channels in period nine.
Unfortunately our $4,000,000 coupon campaign for Allround was a flop. The
number of coupons redeemed was only 1,265,700 or 1.1% of total sales, so it is
apparent that the $0.25 coupon value was not enough to stimulate more redemptions.
We expected to see an increase in unit sales, but we actually sold 7,700,000 fewer units
than the previous period. With these things in mind we will be pulling coupons entirely
for this period, reducing the coupon budget to $0.00. We will continue monitoring social
media comments and the usefulness of coupons to plan another push in coupons in
period nine.
We will continue purchasing surveys to monitor Allround’s shelf space, purchase
intentions, and brand awareness. If these values continue to fall then we will increase
the promotions budget to increase these values and unit sales. But, since these values
did not decrease significantly in period seven, co-op advertising, point of purchase, and
trial size budgets will stay at $800,000, $893,000, and $0.00 respectively. Co-op
advertising and point of purchase budgets will be applied to all channels except
convenience stores because this channel continues to show no growth.
Allround+ did very well this period as far as unit and dollar sales goes. But it’s
brand awareness, purchase intentions, and shelf space showed very minimal growth.
Brand awareness is now at 58.2%, 0.3% higher than last period. Purchase intentions
are now 4.5%, 0.8% higher than the previous period. Overall shelf space did not
change, but there were increases in independent drug stores, chain drugstores, grocery
stores, convenience stores by 0.1 each. Shelf space for mass merchandisers
decreased by 0.1.
Since Allround+’s values that are pertinent to promotional spending showed
such minimal growth tells us that a higher than average promotional budget is not
required for period eight. With this in mind, we are reducing the co-op advertising and
point of purchase budgets to $607,143, $1,097,714, respectively. The values we chose
are the industry averages for co-op advertising and point of purchase spending, and we
chose to do so because this strategy worked well for Allround in previous periods.
Promotional allowance for Allround+ will remain the same in all channels since shelf
space growth is positive and we want it to continue to grow. Trial sizes will no longer be
offered because Allround’s brand awareness is 30.9% stronger than its direct
competitor, Coldcure, and because brand awareness will see little to no growth with
continued trial size spending. Co-op advertising and point of purchase budgets will be
applied to all channels except convenience stores because this channel continues to
show no growth.
Kacy Juneau
Ian Wall
Sade Adelakun
Janelle Harrison
The Coupon budget for Allround+ will remain at $4,000,000 with coupon values
of $1.00 because this proved to be a successful strategy in period seven. Redemptions
reached 2,006,500, or 7.1% of total sales, so we realized a $6,796,665 increase in
dollar sales.
Advertising:
P7 P8 Change
Sales Increase/ Decrease
Expected
Allround 16,825,000 17,475,000 +650,000
111,800,000 / 16,825,000 =
6.645 x 650,000 =
4,319,250
Allround+ 5,950,000 5,950,000 0
28,400,000 / 5,950,000 =
4.773 x 0 = 0
We decided to continue using Sully and Rogers in period eight because they are
the most cost effective, reliable, and they are meeting our requirements. The best way
to allocate the budget for advertising would be to make them both top priorities so we
maintain top brand awareness. We decided to change the advertising expense to,
$17,475,000 to go toward Allround for period eight because the average expense out of
the top four leaders for period five is $17.475 million. Allround already has high brand
awareness which is why we decided on only spending the average budget of all top four
leaders. The top four advertising leaders are End, Allround, Besthelp, and Coughcure.
The budget for End in period eight was $20 million, then Allround was $16.8 million,
Besthelp was $16.8 million, and finally Coughcure with $16.3 million. Adding these
expenses up and dividing by four gives an average advertising budget of $17.475
million. So by changing our advertising expense to $17.475 million we are still applying
the same system, of using the average amount, to compose Allrounds advertising
expense budget. Advertising is a form of communication to create awareness for
products or services. Allround already has high brand awareness so spending the
average instead of the highest amount would be saving the company money and would
be the most ideal system to compose the advertising budget. For the Ad messages in
Allround we decided to keep them the same as period seven and mirror our
percentages with Dryup+ Ad message percentages. With Primary and Benefits at 33%
and Compare and Reminder at 17%. Dryup+ is the only other 4 hour multi-symptom
medicine liquid which is why they would be the better comparison. We want to represent
Kacy Juneau
Ian Wall
Sade Adelakun
Janelle Harrison
Allround as a multi-symptom liquid for all age groups; separate from Allround+. Our
target segments are young singles, young or mature families, empty nesters, the retired,
and cold symptoms that relieves aches, clear nasal congestion, chest congestion, dries
up runny nose, and suppresses coughing. Because those are the most outstanding
symptoms that comes along with having a cold, we want Allround to cover all of the
main cold symptoms and that is why we chose to target those segments.
We decided to spend the same amount for Allround+ in period eight which is
$5,950,000 million of the advertising budget. We are still trying to grow our brand
awareness because we have not been on the market for as long as Coldcure so we are
going to keep the advertising budget the same. Compared to the portfolio graph for
period six Allround+ was a dog that turned into a question mark for period seven
because we increased our advertising; we are now striving to push for a star. We want
Allround+ to have high brand awareness which is why we are using 5.95 of our
advertising expense to compete with coldcure sales and take their potential customers.
We continued to work with Sully and Rogers Advertising agency for Allround+ because
we are now familiar with their work and it is the best cost for us when we still are trying
to make a strong stand in the children’s medication market. The break down for our Ad
messages from last period was, Primary at 40%, Benefits at 40%, Comparison at 10%,
and Reminder at 10%. For period eight we decided to change the Ad message
percentages and mirror Coldcure. From the advertising report it shows that Coldcure
focused more on Compare and Reminder giving us an example to mirror. With Primary
and Benefits at 13% and Comparison and Reminder at 37%. We are also comparing
the Ad message comparison with coldcure because they are the only other children's
medication on the market. We want to represent Allround+ as a children oriented
product for families with young children; separate from Allround. Our target segments
are young families, mature families with grandchildren, and cold symptoms that relieve
aches, clear nasal congestion, chest congestion, dries up runny nose, and suppresses
coughing. Because those are the most prominent symptoms that come along with
having a cold, we want Allround+ to cover all basic cold symptoms for children and that
is why we chose to target those segments.
Kacy Juneau
Ian Wall
Sade Adelakun
Janelle Harrison
5. Price
P7 P8 Change
Sales
Increase/
Decrease
Expected
Average
Discount for
the year:
Allround
MSRP:
$7.04
$7.45
(7.04+0.40) $0.40 increase Allround +0.315
Actual
Selling Price:
$4.82
7.04(1-0.315)
$5.10
7.45(1-0.315)
0.28 increase Allround+ +0.353
Allround+
MSRP:
$6.79
$7.29
(6.79+.50) $0.50 increase
Actual
Selling Price:
$4.39
6.79(1-0.353)
$4.72
7.29(1-0.353)
$0.33 increase
For Allround we decide to implement a 0.40 increase for our price in period eight.
This will make our price for Allround meet the average of our top four competitors
allowing us to reach our goal of being one of the price leaders in the market with a high
price, high quality medication. We took the average of the top four price leaders which
were: Coughcure $8.09, End $7.59, Dyrup+ $7.09, and Allround $7.04. Then we divided
by four and the results were $7.45. We then decided to raise our price to $7.45 to meet
the average of our competitors. We decided to keep our volume discounts the same
because we meet our competitors discount volumes. Coughcure’s volume discount for
period eight are 19% for <250, 24% for <2500, 34% for 2500+, and 38% for
Wholesale.Therefore making our volume discounts at 19% for <250, 24% for <2500,
34% for 2500+, and 38% for Wholesale.
For Allround+ we decided to implement a 0.50 increase for our price in period
eight, which meets Coldcure price for period seven which is $7.29.We want to position
our product as the best quality children's medication, so that is why we have to raise our
price to meet the only other children’s medication, Coldcure.We decided to keep the
same volume discounts for Allround+, because we want to continue to push our
discounts to attract new customers. Therefore making our volume discounts at 27% for
<250, 31% for <2500, 35% for 2500+, and 42% for Wholesale.
Kacy Juneau
Ian Wall
Sade Adelakun
Janelle Harrison
6. Margins
P7 P8 Change
Sales Increase/
Decrease Expected
Allround 270.4/111.8=2.41 2.41+0.28-0.05=2.64 0.23 increase
Allround+ 61.8/28.4=2.17 2.17+0.33-0.05=2.45 0.28 increase
Est. Unit
Cost:
P7 P8 Change
Allround 111.8 $1.67 $1.72 0.05 increase,margin down
Allround+ 28.4 $1.53 $1.58 0.05 increase,margin down
7. Allround Sales Calculations:
7.Sales Calculations:
Allround: 270,400,000/2.64=102,424,242
Last year's sales: 111,800,000
Amt needed to make
same as last yr: 102,424,242-111,800,000=9,375,758
Allround+: 61,800,000/2.45=25,224,489.8
Last year's sales: 28,400,000
Amt needed to make
same as last yr: 25,224,489.8-28,400,000=3,175,510.2
● 102,424,242 is less than last year sales of 111,800,000.So we will need to sell
9,375,758 less due to a margin increase to make the same gross as last year.
● 25,224,489.8 is less than last year sales of 28,400,000 .So we will need to sell
3,175,510.2 less due to a margin increase to make the same gross as last year.
Kacy Juneau
Ian Wall
Sade Adelakun
Janelle Harrison
8. Marketing Research:
For this period we decided to buy six reports. First we purchased the promotion
report for $53,095. We used it to compare promotional allowances with our competitors
to see what numbers to use for Allround and Allround+ by viewing the map and the
promotion allowances percentages. Then we purchased the sales force report for
$30,340. We used this to compare the averages for all the direct and indirect sales force
for Allround and Allround+. Then we purchased the pricing report for $30,340. From this
we discovered we are not the price leader for our new children’s medication, Allround+
when you compare it to the only other children’s medication Coldcure. We also can take
the averages of the four top price leaders and make sure what we need our price to be
to stay in the competition with them. Then we bought the advertising report for $53,095.
From this report we can see who our competitors are using as their marketing agency
and compare the total media expenses with the top four price leaders to find the
average and from there decide what our budget expense should be for both Allround
and Allround+. Then we purchased the purchase survey report for $151,700. From this
report we can see who our brand is most attracted to demographically. We can
compare totals with our competitors to see who is leading in the young family market
because that is the one we need to focus on for our new medication Allround+. Finally
we purchased the shelf space report for $37,925, it helped us decided the promotion
percentages needed for Allround+.

More Related Content

Viewers also liked

Penn Valley Church Announcements 2 12-17 for web (1)
Penn Valley Church Announcements 2 12-17 for web (1)Penn Valley Church Announcements 2 12-17 for web (1)
Penn Valley Church Announcements 2 12-17 for web (1)PennValleyChurch
 
The Top 10 Markets for Mega-Warehouse Construction
The Top 10 Markets for Mega-Warehouse ConstructionThe Top 10 Markets for Mega-Warehouse Construction
The Top 10 Markets for Mega-Warehouse ConstructionKenny Slaught
 
Maria de Noronha-Frei Luis de Sousa
Maria de Noronha-Frei Luis de SousaMaria de Noronha-Frei Luis de Sousa
Maria de Noronha-Frei Luis de Sousananasimao
 
Tutorial 2: Skills Matrix (T27 & T34)
Tutorial 2: Skills Matrix (T27 & T34)Tutorial 2: Skills Matrix (T27 & T34)
Tutorial 2: Skills Matrix (T27 & T34)Comm202
 
Development of Agriculture Technology in the United Provinces (U.P.) during t...
Development of Agriculture Technology in the United Provinces (U.P.) during t...Development of Agriculture Technology in the United Provinces (U.P.) during t...
Development of Agriculture Technology in the United Provinces (U.P.) during t...RSIS International
 
Convict Cowboys interior
Convict Cowboys interiorConvict Cowboys interior
Convict Cowboys interiorJoe Parenteau
 
150hp four stroke
150hp four stroke150hp four stroke
150hp four strokejestercom
 

Viewers also liked (10)

Penn Valley Church Announcements 2 12-17 for web (1)
Penn Valley Church Announcements 2 12-17 for web (1)Penn Valley Church Announcements 2 12-17 for web (1)
Penn Valley Church Announcements 2 12-17 for web (1)
 
Notifiable diseases
Notifiable diseasesNotifiable diseases
Notifiable diseases
 
The Top 10 Markets for Mega-Warehouse Construction
The Top 10 Markets for Mega-Warehouse ConstructionThe Top 10 Markets for Mega-Warehouse Construction
The Top 10 Markets for Mega-Warehouse Construction
 
Maria de Noronha-Frei Luis de Sousa
Maria de Noronha-Frei Luis de SousaMaria de Noronha-Frei Luis de Sousa
Maria de Noronha-Frei Luis de Sousa
 
Tutorial 2: Skills Matrix (T27 & T34)
Tutorial 2: Skills Matrix (T27 & T34)Tutorial 2: Skills Matrix (T27 & T34)
Tutorial 2: Skills Matrix (T27 & T34)
 
Development of Agriculture Technology in the United Provinces (U.P.) during t...
Development of Agriculture Technology in the United Provinces (U.P.) during t...Development of Agriculture Technology in the United Provinces (U.P.) during t...
Development of Agriculture Technology in the United Provinces (U.P.) during t...
 
Convict Cowboys interior
Convict Cowboys interiorConvict Cowboys interior
Convict Cowboys interior
 
Recreación
RecreaciónRecreación
Recreación
 
Slide Share Project
Slide Share ProjectSlide Share Project
Slide Share Project
 
150hp four stroke
150hp four stroke150hp four stroke
150hp four stroke
 

Similar to Report5

Pharmasim final report
Pharmasim final reportPharmasim final report
Pharmasim final reportAuT Tanwichit
 
TABLE OF CONTENTS1. Mission Statement Page 22. Marketing .docx
TABLE OF CONTENTS1. Mission Statement Page 22. Marketing .docxTABLE OF CONTENTS1. Mission Statement Page 22. Marketing .docx
TABLE OF CONTENTS1. Mission Statement Page 22. Marketing .docxmattinsonjanel
 
Running head PharmaSim Final Report1PHARMASIM FINAL REPORT.docx
Running head PharmaSim Final Report1PHARMASIM FINAL REPORT.docxRunning head PharmaSim Final Report1PHARMASIM FINAL REPORT.docx
Running head PharmaSim Final Report1PHARMASIM FINAL REPORT.docxjeanettehully
 
1. MISSION STATEMENTTo provide our customers with the best medi.docx
1. MISSION STATEMENTTo provide our customers with the best medi.docx1. MISSION STATEMENTTo provide our customers with the best medi.docx
1. MISSION STATEMENTTo provide our customers with the best medi.docxjackiewalcutt
 
core assignment paper
core assignment papercore assignment paper
core assignment paperJoe Picurro
 
300297-2-print_ready_revised
300297-2-print_ready_revised300297-2-print_ready_revised
300297-2-print_ready_revisedJessica Phillips
 
1.     Manufacturer’s suggested retail priceAs the board of di.docx
1.     Manufacturer’s suggested retail priceAs the board of di.docx1.     Manufacturer’s suggested retail priceAs the board of di.docx
1.     Manufacturer’s suggested retail priceAs the board of di.docxchristiandean12115
 
Winning PharmaSim Marketing Game Strategy
Winning PharmaSim Marketing Game StrategyWinning PharmaSim Marketing Game Strategy
Winning PharmaSim Marketing Game StrategyLaura Winger
 
Yearly Sales Plan_Square Toiletries Ltd_2019
Yearly Sales Plan_Square Toiletries Ltd_2019Yearly Sales Plan_Square Toiletries Ltd_2019
Yearly Sales Plan_Square Toiletries Ltd_2019Abdur Rakib Mohammad
 
12 keys to innovative marketing planning (002)
12 keys to innovative marketing planning (002)12 keys to innovative marketing planning (002)
12 keys to innovative marketing planning (002)Michael Wolfe
 
Strategic Marketing final presentation (re-submission)
Strategic Marketing final presentation (re-submission)Strategic Marketing final presentation (re-submission)
Strategic Marketing final presentation (re-submission)Kyle Sander
 
160216 investor-presentation-final pacific
160216 investor-presentation-final pacific160216 investor-presentation-final pacific
160216 investor-presentation-final pacificArzish Baaquie
 
Pricing Analytics Case Study
Pricing Analytics Case StudyPricing Analytics Case Study
Pricing Analytics Case StudyMichael Wolfe
 
Lanelle business presentation with sec
Lanelle business presentation with secLanelle business presentation with sec
Lanelle business presentation with secChristyleh Pocong
 
30 Years and Growing1$ at a time30years strong, or.docx
30 Years and Growing1$ at a time30years strong, or.docx30 Years and Growing1$ at a time30years strong, or.docx
30 Years and Growing1$ at a time30years strong, or.docxtamicawaysmith
 
Presentation on Marketing Plan
Presentation on Marketing PlanPresentation on Marketing Plan
Presentation on Marketing PlanAl Shahriar
 
CF Wellness Business Presentation
CF Wellness Business PresentationCF Wellness Business Presentation
CF Wellness Business Presentationcfwellness
 
Fernando Sumondong
Fernando Sumondong Fernando Sumondong
Fernando Sumondong genesum
 

Similar to Report5 (20)

Pharmasim final report
Pharmasim final reportPharmasim final report
Pharmasim final report
 
TABLE OF CONTENTS1. Mission Statement Page 22. Marketing .docx
TABLE OF CONTENTS1. Mission Statement Page 22. Marketing .docxTABLE OF CONTENTS1. Mission Statement Page 22. Marketing .docx
TABLE OF CONTENTS1. Mission Statement Page 22. Marketing .docx
 
Running head PharmaSim Final Report1PHARMASIM FINAL REPORT.docx
Running head PharmaSim Final Report1PHARMASIM FINAL REPORT.docxRunning head PharmaSim Final Report1PHARMASIM FINAL REPORT.docx
Running head PharmaSim Final Report1PHARMASIM FINAL REPORT.docx
 
1. MISSION STATEMENTTo provide our customers with the best medi.docx
1. MISSION STATEMENTTo provide our customers with the best medi.docx1. MISSION STATEMENTTo provide our customers with the best medi.docx
1. MISSION STATEMENTTo provide our customers with the best medi.docx
 
core assignment paper
core assignment papercore assignment paper
core assignment paper
 
300297-2-print_ready_revised
300297-2-print_ready_revised300297-2-print_ready_revised
300297-2-print_ready_revised
 
1.     Manufacturer’s suggested retail priceAs the board of di.docx
1.     Manufacturer’s suggested retail priceAs the board of di.docx1.     Manufacturer’s suggested retail priceAs the board of di.docx
1.     Manufacturer’s suggested retail priceAs the board of di.docx
 
Winning PharmaSim Marketing Game Strategy
Winning PharmaSim Marketing Game StrategyWinning PharmaSim Marketing Game Strategy
Winning PharmaSim Marketing Game Strategy
 
Yearly Sales Plan_Square Toiletries Ltd_2019
Yearly Sales Plan_Square Toiletries Ltd_2019Yearly Sales Plan_Square Toiletries Ltd_2019
Yearly Sales Plan_Square Toiletries Ltd_2019
 
12 keys to innovative marketing planning (002)
12 keys to innovative marketing planning (002)12 keys to innovative marketing planning (002)
12 keys to innovative marketing planning (002)
 
Pharmasim round 3 and 6
Pharmasim round 3 and 6Pharmasim round 3 and 6
Pharmasim round 3 and 6
 
Strategic Marketing final presentation (re-submission)
Strategic Marketing final presentation (re-submission)Strategic Marketing final presentation (re-submission)
Strategic Marketing final presentation (re-submission)
 
160216 investor-presentation-final pacific
160216 investor-presentation-final pacific160216 investor-presentation-final pacific
160216 investor-presentation-final pacific
 
Pricing Analytics Case Study
Pricing Analytics Case StudyPricing Analytics Case Study
Pricing Analytics Case Study
 
Lanelle business presentation with sec
Lanelle business presentation with secLanelle business presentation with sec
Lanelle business presentation with sec
 
30 Years and Growing1$ at a time30years strong, or.docx
30 Years and Growing1$ at a time30years strong, or.docx30 Years and Growing1$ at a time30years strong, or.docx
30 Years and Growing1$ at a time30years strong, or.docx
 
Presentation on Marketing Plan
Presentation on Marketing PlanPresentation on Marketing Plan
Presentation on Marketing Plan
 
CF Wellness Business Presentation
CF Wellness Business PresentationCF Wellness Business Presentation
CF Wellness Business Presentation
 
Fernando Sumondong
Fernando Sumondong Fernando Sumondong
Fernando Sumondong
 
Jerome Bruner
Jerome BrunerJerome Bruner
Jerome Bruner
 

Report5

  • 1. Kacy Juneau Ian Wall Sade Adelakun Janelle Harrison Report 5 1. Summary of Last Year’s Performance: For period seven we had an increase in all of our fields. Our net income is in a growth stage at 26.2 and our revenue is in a growth state at 6.1%. The gross margin is in a growth stage at 13.5%, and finally our stock price increased again from $81.60 to $96.69. Our social media is still generating good comments and feedback from both of our medications. We listened to our Allround customers and gave them coupons this period. Allstar’s consumer satisfaction for period seven increased some what for Allround+ at 48.5% and Allround decreased slightly at 63.5%. We increased the price for both Allround and Allround+ in period seven. Allround was sold at a manufacturing price of $7.04 and sold 111,800,000 units, which is down from last period. Allround+ was sold at a $6.79 manufacturing price with 28,400,000 units sold, which is a growth from last period. Our brand awareness for Allround is 84% and Allround+ is 58.2%. 2. Sales Force Allocation: Sales Force Allround P7 P8 Change Sales Increase/ Decrease Expected Direct: Ind. Drug 13 13 0 3,600,000/13=276,923.1 x0= 0 Chain Drug 35 35 0 23,500,000/35=671,428.57 x0 =0 Grocery Stores 56 55 -1 29,000,000/56=517,857.14 x(-1) = -517,857.14 loss Conv. Stores 5 5 0 900,000/5=180,000 x0= 0 Mass Merch. 16 16 0 12,400,000/16=775,000 x 0= 0 Total Direct: 125 124 -1 =517,857.14 loss Indirect/Wholesalers: Wholesaler Support: 19 18 -1 Data not given Merchandisers 13 14 +1 Data not given Detailers 17 17 0 Data not given Total Indirect/Wholesalers: 49 49 0 42,500,000/49=867,346.94x0= 0 Total Overall: 174 173 -1 0-517,857.14= 517,857.14 units lost
  • 2. Kacy Juneau Ian Wall Sade Adelakun Janelle Harrison SalesForce Allround+ P7 P8 Change Sales Increase/ Decrease Expected Direct: Ind. Drug 13 13 0 1,900,000/13=146,153.85x 0= 0 Chain Drug 35 35 0 6,200,000/35=177,142.86x 0=0 Grocery Stores 56 55 -1 6,000,000/56=107,142.86 x(-1)=107,142.86 loss Conv. Stores 5 5 0 100,000/5=20,000 x 0= 0 Mass Merch. 16 16 0 2,300,000/16=143,750x 0= 0 Total Direct: 125 124 -1 107,142.86 loss Indirect/Wholesalers: Wholesaler Support: 19 18 -1 Data not given Merchandisers 13 14 +1 Data not given Detailers 17 17 0 Data not given Total Indirect/Wholesalers: 49 49 0 11,800,000/49=240,816.33 x0= 0 Total Overall: 174 173 -1 0- 107,142.86= 107,142.86 units lost For the last few periods we have taken the industry averages for direct and indirect sales force and used those calculations to determine what numbers we should use for our company Allstar. From the math calculations below you can see how we found the industry averages for period seven. I decided to round up all the averages that were .2 or higher up. From doing it this way our numbers barely change from the previous period and we still reach our goal of being in the average for indirect and direct sales force. Also being in the average helps us to not push more than needed in the market. This strategy will help us compete with our competitors and not spend more than needed on sales force. Period 7 ALLSTAR B&B CURALL DRISCOL ETHIK AVERAGE: DIRECT INDEP DRUGSTORES 13 14 19 5 10 61/5=12.2 CHAIN DRUGSTORES 35 45 41 18 32 171/5=34.2
  • 3. Kacy Juneau Ian Wall Sade Adelakun Janelle Harrison GROCERY STORES 56 80 57 29 50 272/5=54.4 CONV. STORES 5 9 3 1 4 22/5=4.4 MASSMERCH 16 28 12 8 12 76/5=15.2 INDIRECT WHOLESALER SUPP 19 25 22 11 13 90/5=18 MERCHANDISE RS 13 18 18 7 12 68/5=13.6 DETAILERS 17 30 14 5 17 83/5=16.6 3. Consumer & Trade Promotions: Promotions Allround P7 P8 Change Sales Increase/Decrease Expected Promotion Allowance Independent Drugstores 15.74% 15.74% 0% Chain Drugstores 15.74% 15.74% 0% Grocery Stores 15.74% 15.74% 0% Convenience Stores 15.74% 15.74% 0% Mass Merchandisers 15.74% 15.74% 0% Wholesalers 15.74 15.74% 0% Co-op Advertising $800,000 $800,000 $0.00 Point of Purchase $893,000 $893,000 $0.00 Trial Size $0.00 $0.00 $0.00 Coupon Budget $4,000,000 $0.00 -$4,000,000 Total: $5,693,000 $1,693,000 -4,000,000 111,800,000/5,693,000=19.64X -
  • 4. Kacy Juneau Ian Wall Sade Adelakun Janelle Harrison 4,000,000= -78,560,000 decrease Allround+ P7 P8 Change Sales Increase/Decrease Expected Promotion Allowance Independent Drugstores 18% 18% 0% Chain Drugstores 18% 18% 0% Grocery Stores 11.7% 11.7% 0% Convenience Stores 11.7% 11.7% 0% Mass Merchandisers 11.7 11.7% 0% Wholesalers 18% 18% 0% Co-op Advertising $2,500,000 $607,143 -$1,892,857 Point of Purchase $1,500,000 $1,097,714 -$402,286 Trial Size $1,000,000 $0.00 -$1,000,000 Coupon Budget $4,000,000 $4,000,000 $0.00 Total: $9,000,000 $5,705,428 -$3,294,572 28,400,000/9,000,000=3.156 X - $3,294,572= -10,397,669 decrease Allround remains the leading product in the industry with the highest brand awareness, purchase intentions, and shelf space. However, each of these values have dropped slightly. Currently, brand awareness is 84%, which is .05% less than last period. Purchase intentions are now 19.2%, which is 2% less than last period. Finally, the overall shelf space across all channels is now 1.6, which is .01 less than last period. These values have likely dropped due to a reduction in the promotional allowance for all channels, but we still provide a higher allowance than ten out of twelve of the competing brands including our closest competitor, Besthelp. With that in mind, we will keep
  • 5. Kacy Juneau Ian Wall Sade Adelakun Janelle Harrison promotional allowance at 15.7% in all channels, but if brand awareness, purchase intentions, and shelf space continue to decline then we will increase the allowance for all channels in period nine. Unfortunately our $4,000,000 coupon campaign for Allround was a flop. The number of coupons redeemed was only 1,265,700 or 1.1% of total sales, so it is apparent that the $0.25 coupon value was not enough to stimulate more redemptions. We expected to see an increase in unit sales, but we actually sold 7,700,000 fewer units than the previous period. With these things in mind we will be pulling coupons entirely for this period, reducing the coupon budget to $0.00. We will continue monitoring social media comments and the usefulness of coupons to plan another push in coupons in period nine. We will continue purchasing surveys to monitor Allround’s shelf space, purchase intentions, and brand awareness. If these values continue to fall then we will increase the promotions budget to increase these values and unit sales. But, since these values did not decrease significantly in period seven, co-op advertising, point of purchase, and trial size budgets will stay at $800,000, $893,000, and $0.00 respectively. Co-op advertising and point of purchase budgets will be applied to all channels except convenience stores because this channel continues to show no growth. Allround+ did very well this period as far as unit and dollar sales goes. But it’s brand awareness, purchase intentions, and shelf space showed very minimal growth. Brand awareness is now at 58.2%, 0.3% higher than last period. Purchase intentions are now 4.5%, 0.8% higher than the previous period. Overall shelf space did not change, but there were increases in independent drug stores, chain drugstores, grocery stores, convenience stores by 0.1 each. Shelf space for mass merchandisers decreased by 0.1. Since Allround+’s values that are pertinent to promotional spending showed such minimal growth tells us that a higher than average promotional budget is not required for period eight. With this in mind, we are reducing the co-op advertising and point of purchase budgets to $607,143, $1,097,714, respectively. The values we chose are the industry averages for co-op advertising and point of purchase spending, and we chose to do so because this strategy worked well for Allround in previous periods. Promotional allowance for Allround+ will remain the same in all channels since shelf space growth is positive and we want it to continue to grow. Trial sizes will no longer be offered because Allround’s brand awareness is 30.9% stronger than its direct competitor, Coldcure, and because brand awareness will see little to no growth with continued trial size spending. Co-op advertising and point of purchase budgets will be applied to all channels except convenience stores because this channel continues to show no growth.
  • 6. Kacy Juneau Ian Wall Sade Adelakun Janelle Harrison The Coupon budget for Allround+ will remain at $4,000,000 with coupon values of $1.00 because this proved to be a successful strategy in period seven. Redemptions reached 2,006,500, or 7.1% of total sales, so we realized a $6,796,665 increase in dollar sales. Advertising: P7 P8 Change Sales Increase/ Decrease Expected Allround 16,825,000 17,475,000 +650,000 111,800,000 / 16,825,000 = 6.645 x 650,000 = 4,319,250 Allround+ 5,950,000 5,950,000 0 28,400,000 / 5,950,000 = 4.773 x 0 = 0 We decided to continue using Sully and Rogers in period eight because they are the most cost effective, reliable, and they are meeting our requirements. The best way to allocate the budget for advertising would be to make them both top priorities so we maintain top brand awareness. We decided to change the advertising expense to, $17,475,000 to go toward Allround for period eight because the average expense out of the top four leaders for period five is $17.475 million. Allround already has high brand awareness which is why we decided on only spending the average budget of all top four leaders. The top four advertising leaders are End, Allround, Besthelp, and Coughcure. The budget for End in period eight was $20 million, then Allround was $16.8 million, Besthelp was $16.8 million, and finally Coughcure with $16.3 million. Adding these expenses up and dividing by four gives an average advertising budget of $17.475 million. So by changing our advertising expense to $17.475 million we are still applying the same system, of using the average amount, to compose Allrounds advertising expense budget. Advertising is a form of communication to create awareness for products or services. Allround already has high brand awareness so spending the average instead of the highest amount would be saving the company money and would be the most ideal system to compose the advertising budget. For the Ad messages in Allround we decided to keep them the same as period seven and mirror our percentages with Dryup+ Ad message percentages. With Primary and Benefits at 33% and Compare and Reminder at 17%. Dryup+ is the only other 4 hour multi-symptom medicine liquid which is why they would be the better comparison. We want to represent
  • 7. Kacy Juneau Ian Wall Sade Adelakun Janelle Harrison Allround as a multi-symptom liquid for all age groups; separate from Allround+. Our target segments are young singles, young or mature families, empty nesters, the retired, and cold symptoms that relieves aches, clear nasal congestion, chest congestion, dries up runny nose, and suppresses coughing. Because those are the most outstanding symptoms that comes along with having a cold, we want Allround to cover all of the main cold symptoms and that is why we chose to target those segments. We decided to spend the same amount for Allround+ in period eight which is $5,950,000 million of the advertising budget. We are still trying to grow our brand awareness because we have not been on the market for as long as Coldcure so we are going to keep the advertising budget the same. Compared to the portfolio graph for period six Allround+ was a dog that turned into a question mark for period seven because we increased our advertising; we are now striving to push for a star. We want Allround+ to have high brand awareness which is why we are using 5.95 of our advertising expense to compete with coldcure sales and take their potential customers. We continued to work with Sully and Rogers Advertising agency for Allround+ because we are now familiar with their work and it is the best cost for us when we still are trying to make a strong stand in the children’s medication market. The break down for our Ad messages from last period was, Primary at 40%, Benefits at 40%, Comparison at 10%, and Reminder at 10%. For period eight we decided to change the Ad message percentages and mirror Coldcure. From the advertising report it shows that Coldcure focused more on Compare and Reminder giving us an example to mirror. With Primary and Benefits at 13% and Comparison and Reminder at 37%. We are also comparing the Ad message comparison with coldcure because they are the only other children's medication on the market. We want to represent Allround+ as a children oriented product for families with young children; separate from Allround. Our target segments are young families, mature families with grandchildren, and cold symptoms that relieve aches, clear nasal congestion, chest congestion, dries up runny nose, and suppresses coughing. Because those are the most prominent symptoms that come along with having a cold, we want Allround+ to cover all basic cold symptoms for children and that is why we chose to target those segments.
  • 8. Kacy Juneau Ian Wall Sade Adelakun Janelle Harrison 5. Price P7 P8 Change Sales Increase/ Decrease Expected Average Discount for the year: Allround MSRP: $7.04 $7.45 (7.04+0.40) $0.40 increase Allround +0.315 Actual Selling Price: $4.82 7.04(1-0.315) $5.10 7.45(1-0.315) 0.28 increase Allround+ +0.353 Allround+ MSRP: $6.79 $7.29 (6.79+.50) $0.50 increase Actual Selling Price: $4.39 6.79(1-0.353) $4.72 7.29(1-0.353) $0.33 increase For Allround we decide to implement a 0.40 increase for our price in period eight. This will make our price for Allround meet the average of our top four competitors allowing us to reach our goal of being one of the price leaders in the market with a high price, high quality medication. We took the average of the top four price leaders which were: Coughcure $8.09, End $7.59, Dyrup+ $7.09, and Allround $7.04. Then we divided by four and the results were $7.45. We then decided to raise our price to $7.45 to meet the average of our competitors. We decided to keep our volume discounts the same because we meet our competitors discount volumes. Coughcure’s volume discount for period eight are 19% for <250, 24% for <2500, 34% for 2500+, and 38% for Wholesale.Therefore making our volume discounts at 19% for <250, 24% for <2500, 34% for 2500+, and 38% for Wholesale. For Allround+ we decided to implement a 0.50 increase for our price in period eight, which meets Coldcure price for period seven which is $7.29.We want to position our product as the best quality children's medication, so that is why we have to raise our price to meet the only other children’s medication, Coldcure.We decided to keep the same volume discounts for Allround+, because we want to continue to push our discounts to attract new customers. Therefore making our volume discounts at 27% for <250, 31% for <2500, 35% for 2500+, and 42% for Wholesale.
  • 9. Kacy Juneau Ian Wall Sade Adelakun Janelle Harrison 6. Margins P7 P8 Change Sales Increase/ Decrease Expected Allround 270.4/111.8=2.41 2.41+0.28-0.05=2.64 0.23 increase Allround+ 61.8/28.4=2.17 2.17+0.33-0.05=2.45 0.28 increase Est. Unit Cost: P7 P8 Change Allround 111.8 $1.67 $1.72 0.05 increase,margin down Allround+ 28.4 $1.53 $1.58 0.05 increase,margin down 7. Allround Sales Calculations: 7.Sales Calculations: Allround: 270,400,000/2.64=102,424,242 Last year's sales: 111,800,000 Amt needed to make same as last yr: 102,424,242-111,800,000=9,375,758 Allround+: 61,800,000/2.45=25,224,489.8 Last year's sales: 28,400,000 Amt needed to make same as last yr: 25,224,489.8-28,400,000=3,175,510.2 ● 102,424,242 is less than last year sales of 111,800,000.So we will need to sell 9,375,758 less due to a margin increase to make the same gross as last year. ● 25,224,489.8 is less than last year sales of 28,400,000 .So we will need to sell 3,175,510.2 less due to a margin increase to make the same gross as last year.
  • 10. Kacy Juneau Ian Wall Sade Adelakun Janelle Harrison 8. Marketing Research: For this period we decided to buy six reports. First we purchased the promotion report for $53,095. We used it to compare promotional allowances with our competitors to see what numbers to use for Allround and Allround+ by viewing the map and the promotion allowances percentages. Then we purchased the sales force report for $30,340. We used this to compare the averages for all the direct and indirect sales force for Allround and Allround+. Then we purchased the pricing report for $30,340. From this we discovered we are not the price leader for our new children’s medication, Allround+ when you compare it to the only other children’s medication Coldcure. We also can take the averages of the four top price leaders and make sure what we need our price to be to stay in the competition with them. Then we bought the advertising report for $53,095. From this report we can see who our competitors are using as their marketing agency and compare the total media expenses with the top four price leaders to find the average and from there decide what our budget expense should be for both Allround and Allround+. Then we purchased the purchase survey report for $151,700. From this report we can see who our brand is most attracted to demographically. We can compare totals with our competitors to see who is leading in the young family market because that is the one we need to focus on for our new medication Allround+. Finally we purchased the shelf space report for $37,925, it helped us decided the promotion percentages needed for Allround+.